Novel peptide drug conjugates for the treatment of triple-negative breast cancers: direct anti-tumor activity and immuno-oncology preclinical studies
Ended Cooperative Agreement Awarded Last action
- Award ID
- R43CA221464
- Recipient
-
Oncotherapy Solutions LLC UEI SBJCRLLF26A8
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $300,000
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Place of performance
- Seattle, WA 98103, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $300,000 |
Quick answers
Who received award R43CA221464?
R43CA221464 was awarded to Oncotherapy Solutions LLC by National Cancer Institute (National Institutes of Health) on June 1, 2018.
How much is award R43CA221464 worth?
$300,000 has been obligated on R43CA221464.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award